WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
46.44
+1.30 (+2.88%)
At close: 4:16PM EST
Stock chart is not supported by your current browser
Previous Close45.14
Open45.00
Bid46.40 x 0
Ask46.60 x 0
Day's Range43.85 - 48.78
52 Week Range16.62 - 76.68
Volume5,207,194
Avg. Volume7,156,928
Market Cap15.667B
Beta (3Y Monthly)2.53
PE Ratio (TTM)N/A
EPS (TTM)-0.76
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.83
  • Why Are Traders Shorting Pot Stocks like Canopy Growth Corp (TSX:WEED)?
    The Motley Fool8 hours ago

    Why Are Traders Shorting Pot Stocks like Canopy Growth Corp (TSX:WEED)?

    Data shows that many traders are short pot stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC). Are they right?

  • ACCESSWIRE9 hours ago

    4 Marijuana Stocks Leading Thursday's Bull Charge

    CORAL GABLES, FL / ACCESSWIRE / November 15, 2018 / Marijuana stocks saw a trend reversal on Thursday. Shares of many cannabis stocks that were hit hard over the last few weeks have managed to turn around in price. Since Canada's legalization, a number of new industry events have happened.

  • Cannabis Investors: Have the Beverage Deals Dried Up?
    The Motley Fool12 hours ago

    Cannabis Investors: Have the Beverage Deals Dried Up?

    Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is a high-profile pot stock that could be looking for a beverage maker to partner with.

  • 3 Takeaways From Canopy Growth Corp’s (TSX:WEED) Q2 Earnings
    The Motley Fool12 hours ago

    3 Takeaways From Canopy Growth Corp’s (TSX:WEED) Q2 Earnings

    Canopy Growth Corp (TSX:WEED)(NYSE:CGC) just released earnings for the quarter ended just before legalization. Here's what you need to know.

  • Why Canopy Growth’s Losses Widened in the Second Quarter
    Market Realist13 hours ago

    Why Canopy Growth’s Losses Widened in the Second Quarter

    During the second quarter, Canopy Growth’s (WEED) (CGC) operating losses widened from ~$1 million to almost $214 million. The company reported a net loss of $330 million, which widened from losses of $1.6 million a year ago in 2017.

  • Canopy Growth’s Plans for the Recreational Market
    Market Realist13 hours ago

    Canopy Growth’s Plans for the Recreational Market

    During the second quarter, Canopy Growth’s (WEED) (CGC) registered patients grew almost 34% YoY (year-over-year) to 84,400 patients from 63,000 patients. During the same period, the company’s average selling price per gram increased 24% to $9.87 from $7.99 a year ago. The company stated that the average selling prices increased due to a change in the product mix, which had higher prices. Higher priced products sold in Germany at $13.58 per gram also lifted the average selling prices YoY.

  • Key Takeaways from Canopy Growth’s Second-Quarter Earnings
    Market Realist13 hours ago

    Key Takeaways from Canopy Growth’s Second-Quarter Earnings

    On November 14, Canopy Growth (WEED) (CGC) reported its second-quarter earnings, which largely disappointed the market. As a result, the stock took a beating with an 11% decline to $34.3. The company reported revenues of 23.3 million Canadian dollars, which missed analysts’ estimate of 61.7 million Canadian dollars.

  • Baystreet13 hours ago

    Edibles Producers Catering to California’s New Cannabis Hungry Consumers

    Sales in cannabis-infused edibles products have been on the rise in adult-use legalization markets, ...

  • How Tilray Is Advancing in International Markets
    Market Realist13 hours ago

    How Tilray Is Advancing in International Markets

    In its earnings call, Tilray (TLRY) stated that its Canadian entity will serve as a production hub to meet global cannabis demand and that its Portugal entity will primarily serve as a distribution hub for global markets, specifically focusing on the European Union. The company hopes to create a strong presence in Latin America with its medical cannabis products in Chile and Brazil.

  • Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today
    Motley Foolyesterday

    Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today

    Disappointing quarterly results and a broader market pullback hurt the big Canadian marijuana stocks -- at least temporarily.

  • Canopy Growth shares slip after reporting wider Q2 loss ahead of pot legalization
    The Canadian Pressyesterday

    Canopy Growth shares slip after reporting wider Q2 loss ahead of pot legalization

    Canopy Growth Corp.'s shares fell more than 10 per cent after the cannabis producer reported a wider quarterly loss and revenue slowdown as operating expenses soared ahead of Canada's legalization of recreational pot, which also served as a "distraction" for medical patients. The slowdown in revenues during the quarter ended Sept. 30 stemmed from "hiccups" in shipping medical cannabis to Germany and the "hubbub" around the legalization of adult use pot on Oct. 17 distracting its medical patient base, said Canopy's co-chief executive Bruce Linton.

  • Thomson Reuters StreetEventsyesterday

    Edited Transcript of CGC.TO earnings conference call or presentation 14-Nov-18 1:30pm GMT

    Q2 2019 Canopy Growth Corp Earnings Call

  • The Canadian Pressyesterday

    Most actively traded companies on the TSX

    Some of the most active companies traded Wednesday on the Toronto Stock Exchange:

  • Why PG&E, Switch, and Canopy Growth Slumped Today
    Motley Foolyesterday

    Why PG&E, Switch, and Canopy Growth Slumped Today

    Earnings and liability concerns hit these stocks.

  • Here's Where Marijuana Stocks May Be Headed Next Year
    Investor's Business Dailyyesterday

    Here's Where Marijuana Stocks May Be Headed Next Year

    Canada's marijuana-stocks bubble will pop or at least deflate next year, as soaring valuations hit financial realities, said Chris Walsh, founding editor of Marijuana Business Daily.

  • Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
    Investor's Business Dailyyesterday

    Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike

    Canopy Growth reported deeper losses for fiscal Q2 despite a jump in average sales prices, rounding out a busy earnings week for marijuana stocks.

  • Stocks Rise: Nasdaq Outpaces Dow Jones, Gas Prices Bolster S&P 500
    Investor's Business Dailyyesterday

    Stocks Rise: Nasdaq Outpaces Dow Jones, Gas Prices Bolster S&P 500

    Tech stocks led an early rally Wednesday as tame inflation data drove opening trade, and earnings sent Canada Goose well beyond a buy point.

  • Market Slashes Gains As Apple Stock Hits New Low
    Investor's Business Dailyyesterday

    Market Slashes Gains As Apple Stock Hits New Low

    The Dow Jones industrial average jumped 200 points early on tame inflation, but slashed gains as Apple hit new recent lows. Canada Goose flew and Tesla outperformed.

  • 3 Reasons Canopy Growth Just Posted the Biggest Loss in Its History
    Motley Foolyesterday

    3 Reasons Canopy Growth Just Posted the Biggest Loss in Its History

    And why there's absolutely no reason for investors to worry about it.

  • WeedMD Secures Cannabis Sales License from Health Canada
    Market Realistyesterday

    WeedMD Secures Cannabis Sales License from Health Canada

    WeedMD (WMD) is a Canada-based licensed producer of medical marijuana. On November 13, the company announced that Health Canada approved its cannabis sales license for cannabis cultivated at its greenhouse in Ontario. The below chart lists some key highlights of WeedMD’s greenhouse. According to the company’s press release, the original license, which was issued under the Access to Cannabis for Medical Purposes regulations, was migrated to the license issued under the Cannabis Act regulations.

  • Tilray on Canadian Recreational Market and Future Growth
    Market Realistyesterday

    Tilray on Canadian Recreational Market and Future Growth

    During its 3Q earnings call, Tilray (TLRY) stated that the recreational cannabis market will play a meaningful role for the company as it ramps up supply through increased production capacity. The company updated investors that it recently signed a supply agreement with the province of Prince Edward Island and that its products are currently available in eight provinces. The company is scaling production capacity in anticipation of strong recreational demand. 

  • Bloombergyesterday

    Canopy Revenue Falls Amid ‘Distraction’ of Pot Legalization

    “It is the first time in our history that I’m aware of where we actually had a slowdown, but I think it was more of a distraction than a pattern,” Bruce Linton, head of the No. 2 pot producer by market value said on the company’s earnings call Wednesday. Canopy spent much of the fiscal second quarter, which ended two and a half weeks before Canada legalized recreational pot on Oct. 17, “stress-testing” the provinces’ sales systems at their request. Canopy shares were down 7.7 percent to C$46.49 at 10:38 a.m.

  • Canopy Growth Reports Losses in the Second Quarter
    Market Realistyesterday

    Canopy Growth Reports Losses in the Second Quarter

    On November 14, Canopy Growth (WEED) reported its second-quarter earnings. The company reported revenues of 23 million Canadian dollars, which grew nearly 33% YoY (year-over-year) from 17.6 million Canadian dollars. Other cannabis companies (MJ) reported their earnings earlier this week. Aurora Cannabis (ACB) (ACBFF) reported sales growth of 258%. Tilray (TLRY) reported revenue growth of 60% YoY, while Cronos Group (CRON) reported revenue growth of 187% YoY.

  • What Drove Tilray’s Growth in the Third Quarter?
    Market Realistyesterday

    What Drove Tilray’s Growth in the Third Quarter?

    In its third quarter, Tilray (TLRY) recorded sales growth of 86% year-over-year to $10 million from $5.4 million. The company’s wholesale distribution to international markets also aided in its third-quarter sales growth. What drove sales growth?

  • Canopy Growth Leaves Marijuana Investors Feeling Low
    Motley Foolyesterday

    Canopy Growth Leaves Marijuana Investors Feeling Low

    Quarterly results showed the cannabis company preparing for Canada's recreational rollout.